RIXATHON conc perf 100 mg/10ml 2 amp 10 ml
7680664350012
CH-66435
L01FA01
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 6643501
- CPT
- -
- Packaging group
- 2
- Unit
- Durchstechflasche(n)
- Composition
- rituximabum 100 mg, acidum citricum monohydricum, natrii chloridum, polysorbatum 80, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 35.41 mg.
Articles (1)
Rixathon 100 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
2
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
rituximabum
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
35.41 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 475.35
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2018
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 66435
- Drug name
- Rixathon, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FA01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 03/07/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RIXATHON conc perf 100 mg/10ml 2 amp 10 ml
- Description (DE)
- RIXATHON Inf Konz 100 mg/10ml 2 Amp 10 ml
- Market launch
- 03/07/2018
- Narcotic (BTM)
- No